| Zeit | Aktuelle Nachrichten
Sprache: | | Leser | Medien |
|---|
| 12.05. | ImmunoGen's Management Presents at Credit Suisse Antibody Day Conference (Transcript) | | 2 | Seeking Alpha |
| 09.05. | Immunogen Crosses Below its 10-day MA | | 1 | SmarTrend |
| 06.05. | IMMUNOGEN INC - 10-Q, Quaterly Report | | 5 | SEC Filings |
| 02.05. | Immunogen Bullish Moving Average Crossover Alert | | 3 | SmarTrend |
| 26.04. | ImmunoGen's CEO Discusses F3Q 2013 Results - Earnings Call Transcript | | 9 | Seeking Alpha |
| 15.04. | ImmunoGen to Focus on Pipeline | | 20 | Zacks |
| 14.04. | ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers | | 15 | Seeking Alpha |
| 13.04. | ImmunoGen CEO Hosts Analyst & Investor Day (Transcript) | | 9 | Seeking Alpha |
| 12.04. | ImmunoGen stock drops after it lowers dose in lung cancer trial | | 18 | bizjournals |
| 12.04. | Possible Trend Reversal, Immunogen Down on Heavy Volume | | 7 | SmarTrend |
| 12.04. | Stock Investors Sell Off Shares of Immunogen, Down 4.1% | | 5 | SmarTrend |
| 10.04. | 30.6% Return Seen to Date on SmarTrend Immunogen Call | | 3 | SmarTrend |
| 10.04. | ImmunoGen (IMGN) to Present Preclinical Data on IMGN289 | | 6 | StreetInsider.com |
| 10.04. | ImmunoGen, Inc. Announces Preclinical Findings with its IMGN289 Product Candidate for the Treatment of EGFR-Overexpressing Cancers | | 2 | Benzinga.com |
| 04.04. | ImmunoGen (IMGN), Novartis (NVS) Amend Multi-Target Agreement; May Get $238M in Milestones | | 24 | StreetInsider.com |
| 01.04. | Bearish Moving Average Cross by Immunogen | | 9 | SmarTrend |
| 22.03. | Immunogen Shares Up 23.3% Since SmarTrend's Buy Recommendation | | 10 | SmarTrend |
| 11.03. | After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen | | 32 | Seeking Alpha |
| 28.02. | The Future Of Breast Cancer Treatment And What It Means For Roche And ImmunoGen | | 32 | Seeking Alpha |
| 28.02. | Uptrend Call Working As Immunogen Stock Rises 19.0% | | 5 | SmarTrend |
